Risk factors and mediating mechanisms of restless legs syndrome in patients undergoing maintenance hemodialysis: a longitudinal cohort study combined with Mendelian randomization analysis - Report - MDSpire

Risk factors and mediating mechanisms of restless legs syndrome in patients undergoing maintenance hemodialysis: a longitudinal cohort study combined with Mendelian randomization analysis

  • By

  • Shuge Yao

  • Yucai Zhang

  • Chenghong Ma

  • Huixin Wen

  • Zhenxia Huo

  • Yucong Zhou

  • Liang Wu

  • July 2, 2026

  • 0 min

Share

Clinical Report: Identifying Risk Factors and Pathways for Restless Legs Syndrome

Overview

This study identifies significant risk factors for restless legs syndrome (RLS) in maintenance hemodialysis patients, highlighting the roles of sarcopenia and depressive severity.

Background

Restless legs syndrome (RLS) is prevalent among patients undergoing maintenance hemodialysis, significantly affecting their quality of life. The condition is often exacerbated by factors such as sarcopenia and depression, which are common in this population.

Data Highlights

FactorAdjusted Odds Ratio (OR)p-value
Sarcopenia1.580.002
Depressive Severity1.10<0.001
Multiplicative Interaction1.500.012

Key Findings

  • Sarcopenia and depressive severity are independent predictors of incident RLS in MHD patients.
  • Chronic trajectories of depression, anxiety, frailty, and sarcopenia mediate significant portions of the risk pathways for RLS.
  • Lower estimated glomerular filtration rate (eGFR) is causally associated with increased depression risk.
  • Depression mediates a substantial indirect effect on dopamine metabolism suppression.
  • Anxiety did not show reliable mediating effects in the study.

Clinical Implications

Clinicians should consider screening for sarcopenia and depression in patients undergoing maintenance hemodialysis to identify those at higher risk for RLS. Early intervention targeting these factors may help mitigate the development of RLS and improve patient outcomes.

Conclusion

The study elucidates a complex interplay between renal impairment, psychological distress, and dopamine metabolism in the context of RLS, suggesting the need for multi-faceted screening and intervention strategies.

Related Resources & Content

  1. Frontiers in Neurology, 2026 -- Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis
  2. Frontiers in Neurology, 2026 -- Machine learning for identification of restless legs syndrome-associated factors and classification model development in end-stage renal disease patients
  3. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline | Journal of Clinical Sleep Medicine | Springer Nature Link
  4. Frontiers in Cardiovascular Medicine — Construction of a nomogram prediction model for individualized prediction of the risk of left ventricular diastolic dysfunction in maintenance hemodialysis patients
  5. Intensive Care Medicine — Myocardial Stunning Observed During Intermittent Hemodialysis in Patients with Acute Kidney Injury
  6. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline | Journal of Clinical Sleep Medicine | Springer Nature Link
  7. Frontiers | Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis
  8. Treatment of insomnia, restless legs, cramps, and pain associated with chronic kidney disease: results from a multinational survey of kidney supportive care practice | BMC Nephrology | Springer Nature Link

Original Source(s)

Related Content